Drug Approval Package

 Rebetol (Ribavirin / Ribavirin and Intron A) Combination Therapy
Company:  Schering Corporation
Application No.:  020903s008, s011, s012 & s016
Approval Date: 7/25/2001

• Approval Letter(s) (PDF)    

• Printed Labeling (PDF)    

• Medical Review(s) (PDF)    

• Administrative Document(s) & Correspondence (PDF)  

Date created: April 15, 2005

Back to Top    Drugs@FDA

Note: Documents in PDF format require the Adobe Acrobat Reader®.